Dov Pharmaceutical
9Patents
2Active
9Granted
30Portfolio score
Filing activity: Jan 11, 2001 → Feb 3, 2012 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6372919B1 | (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent | Chemistry; Metallurgy | 33 | Expired |
| US7094799B2 | Polymorphs of bicifadine hydrochloride | Chemistry; Metallurgy | 18 | Expired |
| US6569887B2 | (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake | Chemistry; Metallurgy | 18 | Expired |
| US6716868B2 | (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor | Chemistry; Metallurgy | 17 | Expired |
| US7098229B2 | (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof | Chemistry; Metallurgy | 16 | Expired |
| US7081471B2 | (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor | Chemistry; Metallurgy | 14 | Expired |
| US7098230B2 | (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor | Chemistry; Metallurgy | 13 | Expired |
| US8461196B2 | 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders | Chemistry; Metallurgy | 9 | Active |
| US8138377B2 | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.